Electrical Stimulation for Geographic Atrophy Vision Loss
Part of Eyes & vision clinical trials.
This study tests whether gentle electrical stimulation applied to the eye can help slow vision loss from geographic atrophy, a common cause of blindness in older adults. The treatment uses a special device to stimulate the retina (the light-sensing tissue in the back of your eye).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older
- You have been diagnosed with geographic atrophy (a form of age-related macular degeneration) confirmed by eye imaging
- Your geographic atrophy affects a specific area of your retina that is visible and measurable on imaging
- You have not had recent eye surgery, laser treatment, or injections in the study eye
- You do not have other eye conditions (like retinal detachment, macular edema, or abnormal blood vessel growth) that could interfere with the study
- You are in generally good health and able to follow study visits and procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a gentle electrical stimulation on the eye can slow or improve vision loss in people with open-angle glaucoma. It uses a device you can use at home after training.
This study watches how a treatment called transcorneal electrical stimulation (TES)—which uses gentle electrical pulses on your eye—affects your vision in the short term. You'll be observed while using the OkuStim device, and researchers will ask about any improvements you notice in your sight.
This study tests a device that delivers mild electrical stimulation to the eye to see if it can improve vision in people with early or intermediate dry age-related macular degeneration. It aims to find a safe treatment that may slow down the disease or improve visual function.
This trial tests whether gentle electrical stimulation can help improve vision in people with moderate vision loss from glaucoma. It might offer a new way to strengthen remaining vision.
This trial tests a new nerve stimulation treatment for people with geographic atrophy, a form of advanced dry age-related macular degeneration. It aims to see if this treatment can help preserve or improve vision.
This study tests a non-invasive brain stimulation treatment to see if it can improve peripheral (side) vision in people with open-angle or normal-tension glaucoma. It targets people whose central vision is still relatively preserved but whose side vision has a measurable “gap” on vision testing.
Hear when a new Geographic Atrophy Secondary to Age-related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.